The director's cluster of open-market buys totaling ~$950K at ~$9.14-$9.36 per share signals insider conviction near current levels. Monitor for additional insider buying or upcoming catalysts (e.g., pipeline data, regulatory updates) that could validate this signal. The stock's 89% analyst bullish consensus and recent institutional accumulation (7 adds, 6 doubled) provide a supportive backdrop.
Price Chart
Executive Summary
Director Gregory Ciongoli made a $450K open-market purchase of RGNX shares at $9.14 on August 26, adding to a $500K purchase the prior day, bringing his total cluster buys to ~$950K. This is a standalone conviction buy by a director, representing ~0.15% of the $619M market cap, which is a modest but notable signal. The purchase follows a non-cash grant of 69,609 shares on August 25, suggesting the director is increasing his economic exposure beyond compensation.
Key Financial Metrics
Key Facts
- Director Gregory Ciongoli purchased 49,196 shares at $9.14 for $450K on August 26, 2026.
- This follows a $500K purchase on August 25 and a non-cash grant of 69,609 shares on the same date.
- Total insider buying in the last 30 days is $949K, all by this director.
- The purchase represents ~0.15% of RGNX's $619M market cap, a modest but material signal.
Financial Impact
$450K open-market purchase by a director, representing ~0.15% of market cap.
Risk Factors
- Single insider (director, not C-suite) limits signal strength; C-suite participation would be more compelling.
- Historical calibration shows mixed T+20 outcomes for score-6/7 reports on RGNX, with high volatility.
- Biotech sector risk: pipeline setbacks or regulatory delays could reverse any near-term gains.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0002023732-26-000008 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | Insider Buy | $9.66 $7.47 | ▼ −22.67% | ▼ −22.93% | $7.43 (−23.08%) |
Aug 25, 2026 5w ago | 8-K | $9.38 $7.24 | ▼ −22.81% | ▼ −23.04% | $7.43 (−20.79%) |
Aug 6, 2026 8w ago | 8-K | $11.28 $9.20 | ▼ −18.44% | ▼ −19.04% | $7.43 (−34.13%) |
Aug 3, 2026 8w ago | Press Release | $9.96 $9.50 | ▼ −4.62% | ▼ −5.86% | $7.43 (−25.40%) |
Jul 20, 2026 10w ago | 8-K | $10.32 $11.33 | ▼ −9.79% | ▼ −5.67% | $7.43 (+28.00%) |
Jul 17, 2026 11w ago | Press Release | $9.89 $10.77 | ▼ −8.85% | ▼ −4.40% | $7.43 (+24.87%) |
Jun 29, 2026 13w ago | 8-K | $11.83 $9.73 | ▼ −17.75% | ▼ −17.47% | $7.43 (−37.19%) |
Jun 3, 2026 17w ago | 8-K | $6.69 $13.28 | ▲ +98.51% | ▲ +99.51% | $7.43 (+11.06%) |
May 14, 2026 20w ago | 8-K | $6.25 $6.66 | ▲ +6.65% | ▲ +7.50% | $7.43 (+18.98%) |
Mar 5, 2026 30w ago | 8-K | $8.72 $8.53 | ▼ −2.18% | ▲ +1.61% | $7.43 (−14.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access